| Financial Year |
March 31 2023 |
| Monetary Funds |
771,036,761.13 |
| Held-for-trading Financial Assets |
4,814,454.13 |
| Notes Receivable |
-- |
| Accounts Receivable |
126,514,002.42 |
| Advances to Suppliers |
17,752,374.66 |
| Other Receivables |
11,759,594.88 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
405,544,398.34 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,243,507.10 |
| Total Current Assets |
1,377,070,424.02 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
55,216,257.22 |
| Investment Properties |
-- |
| Fixed Assetes |
665,378,640.07 |
| Under-construction Projects |
41,866,312.60 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
78,421,949.58 |
| R&D expenses |
-- |
| Goodwill |
17,432,184.24 |
| Long-Term Deferred and Prepaid Expenses |
3,482,960.10 |
| Deferred Income Tax Assets |
14,904,079.28 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
908,059,450.30 |
| Total Assets |
2,285,129,874.32 |
| Short-Term Loans |
137,110,513.76 |
| Trading Financial liabilities |
-- |
| Notes Payable |
55,350,000.00 |
| Accounts Payable |
279,148,146.33 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
52,129,825.85 |
| Taxes Payable |
10,437,858.48 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
28,144,803.41 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
24,155,835.23 |
| Other Current Liabilities |
697,423.42 |
| Sub-Total of Current Liabilities |
620,554,011.05 |
| Long-term Loans |
250,197,417.83 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
973,510.34 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
275,758,716.13 |
| Total Liabilities |
896,312,727.18 |
| Paid-In Capital(Or Share Stock) |
466,749,332.00 |
| Capital Surplus |
332,385,822.70 |
| Surplus Reserve |
145,202,096.11 |
| LESS:Treasury Stock |
18,026,700.00 |
| Undistributed Profits |
481,227,071.45 |
| Minority Stockholder's Interest |
-15,538,172.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,404,355,319.99 |
| Owner's Equity（Stockholder's Equity） |
1,388,817,147.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,285,129,874.32 |
